BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19679656)

  • 1. Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
    Lee DW; Rajagopalan S; Siddiq A; Gwiazda R; Yang L; Beal MF; Ratan RR; Andersen JK
    J Biol Chem; 2009 Oct; 284(42):29065-76. PubMed ID: 19679656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.
    Rajagopalan S; Rane A; Chinta SJ; Andersen JK
    J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y; Ye D; Ding Y; Wei N
    Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
    [No Abstract]   [Full Text] [Related]  

  • 5. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.
    Niatsetskaya Z; Basso M; Speer RE; McConoughey SJ; Coppola G; Ma TC; Ratan RR
    Antioxid Redox Signal; 2010 Apr; 12(4):435-43. PubMed ID: 19659431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
    Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
    FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.
    Siddiq A; Aminova LR; Troy CM; Suh K; Messer Z; Semenza GL; Ratan RR
    J Neurosci; 2009 Jul; 29(27):8828-38. PubMed ID: 19587290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM; Câmpean V; Kany S; Jürgensen JS; Weidemann A; Warnecke C; Arend M; Klaus S; Günzler V; Amann K; Willam C; Wiesener MS; Eckardt KU
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point.
    Khanna S; Roy S; Maurer M; Ratan RR; Sen CK
    Free Radic Biol Med; 2006 Jun; 40(12):2147-54. PubMed ID: 16785028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces haem oxygenase-1 expression in human cells through a mechanism independent of hypoxia-inducible factor-1alpha.
    Li B; Takeda K; Yokoyama S; Shibahara S
    J Biochem; 2008 Nov; 144(5):643-54. PubMed ID: 18799519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
    Floyd ZE; Kilroy G; Wu X; Gimble JM
    J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.
    Martin F; Linden T; Katschinski DM; Oehme F; Flamme I; Mukhopadhyay CK; Eckhardt K; Tröger J; Barth S; Camenisch G; Wenger RH
    Blood; 2005 Jun; 105(12):4613-9. PubMed ID: 15741220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism.
    Madai S; Kilic P; Schmidt RM; Bas-Orth C; Korff T; Büttner M; Klinke G; Poschet G; Marti HH; Kunze R
    Theranostics; 2024; 14(7):2856-2880. PubMed ID: 38773968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases
    Li X; Cui XX; Chen YJ; Wu TT; Xu H; Yin H; Wu YC
    Front Aging Neurosci; 2018; 10():121. PubMed ID: 29755339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.
    Berchner-Pfannschmidt U; Yamac H; Trinidad B; Fandrey J
    J Biol Chem; 2007 Jan; 282(3):1788-96. PubMed ID: 17060326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia.
    Agani FH; Pichiule P; Chavez JC; LaManna JC
    J Biol Chem; 2000 Nov; 275(46):35863-7. PubMed ID: 10961998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
    Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
    J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.
    Ogle ME; Gu X; Espinera AR; Wei L
    Neurobiol Dis; 2012 Feb; 45(2):733-42. PubMed ID: 22061780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.